flow trial semaglutide kidney outcomes effects on kidneys and creatinine of Once-Weekly Disease by KDIGO Risk Category in the SUSTAIN 6 In participants with type 2 Diabetes Distilled: Keeping kidneys FLOWing – Diabetes Distilled: Keeping kidneys FLOWing

10.1016/j.ccr.2015.09.001 127 PucciD.BloiseR.BellusciA.BernardiniS.GhediniM.PirilloS.et al (2007)

What is known comes from small studies, case reports, and user-reported side effects

Patient monitoring should include: Baseline lipid panel, hemoglobin A1c, and liver function tests Blood pressure monitoring (GLP-1 agents typically reduce systolic BP by 3-5 mmHg) [10] Assessment for gastrointestinal adverse effects during dose titration Evaluation for contraindications (personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2) [1] [3] Monitoring for gallbladder disease (increased risk with rapid weight loss) In patients with diabetes and retinopathy, monitoring for worsening eye symptoms, particularly with rapid glycemic improvement Renal function assessment, especially if severe gastrointestinal symptoms cause dehydration Patients should seek immediate medical attention for severe abdominal pain, which may indicate pancreatitisa rare but serious adverse effect

Slforafan ieren brokoli, kkrt ieren sarmsak ve soan, N-asetilsistein kayna olan yumurta ve baklagiller destekleyici besinler arasndadr

At AgeRejuvenation, medical weight loss is built around your labs and your body composition, not a one-size injection

While not a primary mechanism of action, the metabolic improvements and reduced late-night eating often translate to better rest